2018
DOI: 10.1242/jcs.215939
|View full text |Cite
|
Sign up to set email alerts
|

Sensory neuronal sensitisation occurs through HMGB-1–RAGE and TRPV1 in high-glucose conditions

Abstract: Many potential causes for painful diabetic neuropathy have been proposed including actions of cytokines and growth factors. High mobility group protein B1 (HMGB1) is a RAGE (also known as AGER) agonist whose levels are increased in diabetes and that contributes to pain by modulating peripheral inflammatory responses. HMGB1 enhances nociceptive behaviour in naïve animals through an unknown mechanism. We tested the hypothesis that HMGB1 causes pain through direct neuronal activation of RAGE and alteration of noc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
27
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(30 citation statements)
references
References 72 publications
2
27
1
Order By: Relevance
“…Under high-glucose conditions, TRPV1 expression in endothelial cells was not affected. Contrary to possible desensitization, high-glucose conditions are reported to rather sensitize TRPV1, resulting in increased agonist-evoked calcium responses in diabetes (41,42). In dorsal root ganglia, increased TRPV1 sensitivity is suggested to link to early painful diabetic neuropathy (43), further supporting the assumption that TRPV1 signaling is not compromised under diabetic conditions.…”
Section: Methodsmentioning
confidence: 92%
“…Under high-glucose conditions, TRPV1 expression in endothelial cells was not affected. Contrary to possible desensitization, high-glucose conditions are reported to rather sensitize TRPV1, resulting in increased agonist-evoked calcium responses in diabetes (41,42). In dorsal root ganglia, increased TRPV1 sensitivity is suggested to link to early painful diabetic neuropathy (43), further supporting the assumption that TRPV1 signaling is not compromised under diabetic conditions.…”
Section: Methodsmentioning
confidence: 92%
“…Therefore, we cannot exclude that our differing observations may be due to animal age. Moreover, ligands that can accompany diabetic conditions and activate RAGE, such as the inflammatory cytokine high-mobility group box-protein 1 (HMGB1, also known as amphoterin) and methylglyoxal, may contribute to pain behavior in diabetic neuropathy via TRPV1 or transient receptor potential ankyrin 1 (TRPA1)-dependent mechanisms [ 31 , 32 ].…”
Section: Discussionmentioning
confidence: 99%
“…vF filaments of increasing diameter were applied (a maximum of five seconds or until paw withdrawal), with each vF filament applied a total of 5 times to generate force response curves. Withdrawal frequencies of 50% at each weight was used to determine the mechanical withdrawal threshold (g) (21). The Hargreaves test was performed to measure thermal nociceptive behaviour (22).…”
Section: Nociceptive Behaviourmentioning
confidence: 99%